Obstructive Ventilatory Dysfunctions-Functional Assessment and Rehabilitation Program
- PMID: 39371060
- PMCID: PMC11447504
- DOI: 10.12865/CHSJ.50.02.15
Obstructive Ventilatory Dysfunctions-Functional Assessment and Rehabilitation Program
Abstract
Background: Obstructive ventilatory dysfunctions have an increased incidence, and through functional assessment determined by the International Classification of Functioning, Disability and Health (ICF), appropriate treatment can be established.
Aims: The objectives of our research are represented by the application of respiratory rehabilitation sessions according to the ICF in patients with obstructive ventilatory dysfunctions-with COPD or asthma, using a unique, international language and the evaluation of the results obtained before and after completion pulmonary rehabilitation.
Methods: We conducted a randomized prospective study between November 2022-April 2023, which included 84 patients diagnosed with obstructive ventilatory dysfunctions and who performed respiratory rehabilitation. They were divided into two categories: category 1-C1 which included 43 patients with Chronic Obstructive Pulmonary Disease-COPD and category 2-C2 which included 41 patients diagnosed with asthma. The rehabilitation program lasted 8 weeks, with exercises performed from Monday to Friday, with a weekend break. Respiratory rehabilitation consisted of physical therapy, inspiratory and expiratory muscle training (IEMT), proper nutrition, and psychotherapy.
Results: At the end of the program, most of the patients showed improvements in the ICF qualifiers, a fact that supported us that respiratory recovery is one of the basic therapies of patients with obstructive ventilatory dysfunctions.
Conclusions: The ICF allows the application of a personalized respiratory rehabilitation program. The ICF qualifiers are used for the functional assessment of patients and allow they to be included in individualized medical rehabilitation programs.
Keywords: ICF; Respiratory rehabilitation; obstructive ventilatory dysfunctions.
Copyright © 2022, Medical University Publishing House Craiova.
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures
References
-
- Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391(10122):783–800. - PubMed
-
- Venkatachalam P, Dwivedi DP, Govindraj V. FEV1/FEV6 is effective as a surrogate for FEV1/FVC in the diagnosis of chronic obstructive pulmonary disease. Indian J Tuberc. 2021;68(2):230–235. - PubMed
-
- Amin AN, Cornelison S, Woods JA, Hanania NA. Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team. Postgrad Med. 2022;134(2):152–159. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous